Director, US Real-World Evidence & Health Outcomes -Multiple Myeloma

The role of Director, US Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology ensures that each medicine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and solid evidence-based product positioning, value propositions, and value-based pricing. The role is accountable for developing and delivering components of the US data generation plan (including RWE and economic value evidence), ensuring strategic alignment across key internal stakeholders (US Medical, Commercial/Market Access, Global RWE & HO, Global Medical Affairs, R&D; Epidemiology and Clinical Development), and driving high-quality deliverables that inform internal decision-making during product development, pre-launch readiness, and lifecycle planning. This role promises a fast-paced environment supporting a current-to-market product in a dynamic hematology space.

Responsibilities

- Evidence strategy and planning:



Implementation of RWE/HO research by developing evidence generation plan and designing multiple RWE/HO studies, aligned to US medical, payer, and access needs; translate strategy into actionable workplans, timelines, and resourcing proposals. Translate needs for evidence into study concepts in alignment with strategic objectives and vision for the asset, e.g. development of study protocols and proposing innovative and cost-effective ways of developing and executing studies
- Study leadership (RWE/HEOR): Own day-to-day leadership for assigned real-world evidence and health outcomes studies (e.g., real-world evidence studies, cost‑effectiveness/budget impact analyses, burden of illness, treatment patterns, patient‑focused outcomes) including design and execution in partnership with internal functions and external vendors.
- Ensure key stakeholders, including TA aligned business leaders, are regularly updat

📌 Intern, Logistics R&D, Argentina, 2026 (Melbourne)
🏢 Gsk
📍 Melbourne